Robert J. Adelman, 10% Owner at Akero Therapeutics, Inc. (AKRO), sold 70,996 shares at $19.30 ($1.4M) on 2020-01-03, disclosed to the SEC on 2020-01-06.
Open-market sale of $1.4M AKRO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.94 | 23,000 | $459K | 32.8% |
| 2 | $19.94 | 23,000 | $459K | 32.8% |
| 3 | $19.30 | 12,498 | $241K | 17.2% |
| 4 | $19.30 | 12,498 | $241K | 17.2% |
| Total | $19.71 avg | 70,996 | $1.4M | 100% |
| Filing → |
| AKRO | SELL | 2020-03-03 | $731K | — | Filing → |
| ARYX | BUY | 2007-11-14 | $3.0M | — | Filing → |